US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kazia Therapeutics Limited

5.26

-0.2000-3.66%

Volume:181.20K

Turnover:945.14K

Market Cap:59.63M

PE:-0.42

High:5.75

Open:5.51

Low:5.03

Close:5.46

52wk High:17.40

52wk Low:2.86

Shares:11.34M

Float Shares:10.58M

Volume Ratio:1.59

T/O Rate:1.71%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-12.3849

EPS(LYR):-12.3849

ROE:-3891.64%

ROA:-64.28%

PB:-10.09

PE(LYR):-0.42

Loading ...

Overview Company News Filings

BRIEF-Kazia Therapeutics Announces Pricing Of $50.0 Million Private Placement Of Equity Securities

BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet

BUZZ-Microcap Kazia shares soar 40% after positive drug update on single-patient treatment

What Sparked Kazia Therapeutics' Over 51% After-Hours Surge?

Benzinga_recent_news

Kazia Therapeutics Reports Initial iCR in Metastatic TNBC and Advances Pipeline Programs

Kazia Therapeutics reports A$42,000 revenue for fiscal year 2025

Kazia Therapeutics Delays Annual Financial Report Filing

BRIEF-Kazia Therapeutics To Request FDA Type C Meeting To Discuss Overall Survival Data In GBM And Potential NDA Filing In Alignment With FDA Initiative Project Frontrunner

Kazia Therapeutics Ltd - Seeks FDA Feedback on Regulatory Pathway Under Project Frontrunner for Paxalisib

THOMSON REUTERS

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential Nda Filing in Alignment With FDA Initiative Project Frontrunner

THOMSON REUTERS

Kazia Therapeutics Enters Exclusive Collaboration with QIMR Berghofer to Develop First-in-Class PD-L1 Protein Degrader for Cancer Treatment

BRIEF-Kazia Therapeutics Announces Collaboration And In-Licensing Agreement For First-In-Class PD-L1 Protein Degrader Program

Kazia Therapeutics signs collaboration and in-licensing agreement for PD-L1

Kazia Therapeutics Announces Collaboration and in-Licensing Agreement for First-in-Class Pd-L1 Protein Degrader Program

THOMSON REUTERS

Kazia Therapeutics Ltd - to Make $1.39 Mln Payment Under Agreement

THOMSON REUTERS

Kazia Therapeutics Ltd: Announces 86% Tumor Reduction in Tnbc Patient Treated With Paxalisib-Immunotherapy Regimen

THOMSON REUTERS

Kazia Therapeutics Ltd - Imaging Shows 86% Tumor Reduction After Three Weeks of Therapy

THOMSON REUTERS

Kazia Therapeutics Announces Promising Results in Phase 1b Trial for Paxalisib Combination Therapy in Advanced Breast Cancer, Reports 86% Tumor Reduction in Metastatic TNBC Patient

Kazia Therapeutics Ltd : Maxim Group Raises Target Price to $20 From $15

THOMSON REUTERS

Kazia Therapeutics Joins Australian Consortium to Develop AI-Driven, Personalized Therapy Strategies for Childhood Brain Cancers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KZIA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KZIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KZIA\",,,,,undefined,":{"symbol":"KZIA","market":"US","secType":"STK","nameCN":"Kazia Therapeutics Limited","latestPrice":5.26,"timestamp":1770843600000,"preClose":5.46,"halted":0,"volume":181195,"delay":0,"changeRate":-0.03663003663003666,"floatShares":10583400,"shares":11336000,"eps":-12.38492,"marketStatus":"Pre-Mkt","change":-0.2,"latestTime":"02-12 04:40:54 EST","open":5.51,"high":5.75,"low":5.03,"amount":945140.2992499999,"amplitude":0.131868,"askPrice":5.75,"askSize":100,"bidPrice":4.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-12.38492,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770906600000},"marketStatusCode":1,"adr":0,"adrRate":500,"exchange":"NASDAQ","adjPreClose":5.26,"postHourTrading":{"tag":"盘后","latestPrice":5.26,"preClose":5.26,"latestTime":"17:23 EST","volume":19,"amount":99.94,"timestamp":1770848619315,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.5914456551662122,"impliedVol":2.4006,"impliedVolPercentile":0.7091},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KZIA\",,,,,undefined,":{"symbol":"KZIA","floatShares":10583400,"roa":"-64.28%","roe":"-3891.64%","lyrEps":-12.38492,"volumeRatio":1.5914456551662122,"shares":11336000,"dividePrice":0,"high":5.75,"amplitude":0.131868,"preClose":5.46,"low":5.03,"week52Low":2.86,"pbRate":"-10.09","psRate":"45.81","week52High":17.4,"institutionHeld":0.0283,"latestPrice":5.26,"eps":-12.38492,"divideRate":0,"volume":181195,"delay":0,"ttmEps":-12.38492,"open":5.51,"prevYearClose":6.89,"prevWeekClose":5.79,"prevMonthClose":5.86,"prevQuarterClose":6.89,"fiveDayClose":5.995,"twentyDayClose":6.3,"sixtyDayClose":7.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KZIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-17","symbol":"KZIA","defaultRemindTime":1744896600000,"type":"split","dateTimestamp":1744862400000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-10-28","symbol":"KZIA","defaultRemindTime":1730122200000,"type":"split","dateTimestamp":1730088000000,"forFactor":10,"toFactor":1,"ratio":10},{"date":"2024-03-27","symbol":"KZIA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711526400000,"name":null,"time":"Pre-Market","dateTimestamp":1711512000000,"actualEps":null},{"date":"2023-10-30","symbol":"KZIA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698696000000,"name":null,"time":"Post Market","dateTimestamp":1698638400000,"actualEps":null},{"market":"US","date":"2023-08-31","symbol":"KZIA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1693454400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KZIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KZIA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1752123600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KZIA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KZIA","date":"2026-02-10","current":-0.42471,"percent":0.321138,"low":-24.844496,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"high":-0.201874,"avg":-4.956489,"sd":6.719268,"marketCap":62326887},"quantilePoints":[{"date":"2021-02-12","current":-11.637327,"twenty":-6.313122,"median":-4.089744,"eighty":-2.406328,"marketCap":112523637.35},{"date":"2021-02-19","current":-11.822046,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":116010201.5},{"date":"2021-02-26","current":-12.909062,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":128969525.54},{"date":"2021-03-05","current":-12.509338,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":124000257.96},{"date":"2021-03-12","current":-12.949119,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":130102441.62},{"date":"2021-03-19","current":-13.587043,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":136300287.4},{"date":"2021-03-26","current":-14.173534,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":140003819.22},{"date":"2021-04-01","current":-15.965018,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":157208157.55},{"date":"2021-04-09","current":-18.217137,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":179836122.88},{"date":"2021-04-16","current":-15.314406,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":153343482.56},{"date":"2021-04-23","current":-14.013182,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":140379423.69},{"date":"2021-04-30","current":-14.013182,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":139827770.84},{"date":"2021-05-07","current":-13.612806,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":138337649.69},{"date":"2021-05-14","current":-12.661911,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":127473944.65},{"date":"2021-05-21","current":-12.411676,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":124326443.38},{"date":"2021-05-28","current":-12.111393,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":120832523.88},{"date":"2021-06-04","current":-12.711958,"twenty":-6.323923,"median":-4.083672,"eighty":-2.404517,"marketCap":127442777.73},{"date":"2021-06-11","current":-13.112335,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":130657625.42},{"date":"2021-06-18","current":-13.512711,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":130978640.72},{"date":"2021-06-25","current":-13.112335,"twenty":-6.323923,"median":-4.089744,"eighty":-2.406328,"marketCap":129039174.71},{"date":"2021-07-02","current":-13.212429,"twenty":-6.353408,"median":-4.089744,"eighty":-2.406328,"marketCap":128279242.77},{"date":"2021-07-09","current":-13.312523,"twenty":-6.360074,"median":-4.089744,"eighty":-2.406328,"marketCap":128893500.56},{"date":"2021-07-16","current":-13.062288,"twenty":-6.441961,"median":-4.089744,"eighty":-2.406328,"marketCap":125290384.42},{"date":"2021-07-23","current":-13.212429,"twenty":-6.441961,"median":-4.089744,"eighty":-2.406328,"marketCap":126104697.82},{"date":"2021-07-30","current":-12.361629,"twenty":-6.682885,"median":-4.089744,"eighty":-2.406328,"marketCap":117602941.52},{"date":"2021-08-06","current":-12.411676,"twenty":-6.764059,"median":-4.089744,"eighty":-2.406328,"marketCap":118157190.33},{"date":"2021-08-13","current":-12.411676,"twenty":-6.971389,"median":-4.089744,"eighty":-2.406328,"marketCap":118558107.25},{"date":"2021-08-20","current":-12.561817,"twenty":-7.106591,"median":-4.089744,"eighty":-2.406328,"marketCap":116013073.03},{"date":"2021-08-27","current":-21.63117,"twenty":-7.208926,"median":-4.089744,"eighty":-2.406328,"marketCap":132878809.63},{"date":"2021-09-03","current":-23.041898,"twenty":-7.286038,"median":-4.093172,"eighty":-2.408138,"marketCap":144442089.32},{"date":"2021-09-10","current":-22.728403,"twenty":-7.296419,"median":-4.093172,"eighty":-2.408138,"marketCap":141049077.44},{"date":"2021-09-17","current":-22.25816,"twenty":-7.335154,"median":-4.093172,"eighty":-2.408138,"marketCap":136332608},{"date":"2021-09-24","current":-24.766122,"twenty":-7.378041,"median":-4.093172,"eighty":-2.408138,"marketCap":151155366.33},{"date":"2021-10-01","current":-23.982384,"twenty":-7.462667,"median":-4.093172,"eighty":-2.408138,"marketCap":146605704.43},{"date":"2021-10-08","current":-22.806777,"twenty":-7.527319,"median":-4.096601,"eighty":-2.409949,"marketCap":140459059.6},{"date":"2021-10-15","current":-23.041898,"twenty":-7.66309,"median":-4.096601,"eighty":-2.409949,"marketCap":144034696.8},{"date":"2021-10-22","current":-23.355394,"twenty":-7.781029,"median":-4.096601,"eighty":-2.409949,"marketCap":146965175.58},{"date":"2021-10-29","current":-22.728403,"twenty":-8.206083,"median":-4.096601,"eighty":-2.409949,"marketCap":143653060.41},{"date":"2021-11-05","current":-24.609375,"twenty":-8.518821,"median":-4.096601,"eighty":-2.409949,"marketCap":153457106.47},{"date":"2021-11-12","current":-24.295879,"twenty":-10.298084,"median":-4.096601,"eighty":-2.409949,"marketCap":149849083.12},{"date":"2021-11-19","current":-23.982384,"twenty":-10.778381,"median":-4.096601,"eighty":-2.409949,"marketCap":146563151.44},{"date":"2021-11-26","current":-21.63117,"twenty":-10.990809,"median":-4.096601,"eighty":-2.409949,"marketCap":129672466.37},{"date":"2021-12-03","current":-22.414908,"twenty":-11.083168,"median":-4.096601,"eighty":-2.409949,"marketCap":132540516.75},{"date":"2021-12-10","current":-17.869227,"twenty":-11.221708,"median":-4.096601,"eighty":-2.409949,"marketCap":107919625.67},{"date":"2021-12-17","current":-16.853559,"twenty":-11.455877,"median":-4.096601,"eighty":-2.409949,"marketCap":101581620.98},{"date":"2021-12-23","current":-17.872611,"twenty":-11.591456,"median":-4.096601,"eighty":-2.409949,"marketCap":108861226.59},{"date":"2021-12-31","current":-19.67555,"twenty":-11.822046,"median":-4.096601,"eighty":-2.409949,"marketCap":120487673.23},{"date":"2022-01-07","current":-18.656498,"twenty":-12.007673,"median":-4.096601,"eighty":-2.411759,"marketCap":112674276.08},{"date":"2022-01-14","current":-17.559057,"twenty":-12.099126,"median":-4.096601,"eighty":-2.411759,"marketCap":106843200.64},{"date":"2022-01-21","current":-16.22645,"twenty":-12.211487,"median":-4.096601,"eighty":-2.411759,"marketCap":98464234.45},{"date":"2022-01-28","current":-14.423511,"twenty":-12.312042,"median":-4.096601,"eighty":-2.411759,"marketCap":84958897.75},{"date":"2022-02-04","current":-14.854648,"twenty":-12.361629,"median":-4.096601,"eighty":-2.411759,"marketCap":88376133.79},{"date":"2022-02-11","current":-17.167113,"twenty":-12.411676,"median":-4.096601,"eighty":-2.411759,"marketCap":103738783.81},{"date":"2022-02-18","current":-16.853559,"twenty":-12.411676,"median":-4.096601,"eighty":-2.411759,"marketCap":101880562.02},{"date":"2022-02-25","current":-8.436054,"twenty":-12.421685,"median":-4.096601,"eighty":-2.411759,"marketCap":92997383.52},{"date":"2022-03-04","current":-8.046698,"twenty":-12.421685,"median":-4.096601,"eighty":-2.411759,"marketCap":90223808.96},{"date":"2022-03-11","current":-7.61408,"twenty":-12.421685,"median":-4.096601,"eighty":-2.411759,"marketCap":84923799.88},{"date":"2022-03-18","current":-7.657341,"twenty":-12.421685,"median":-4.11788,"eighty":-2.411759,"marketCap":86506462.1},{"date":"2022-03-25","current":-8.392792,"twenty":-12.421685,"median":-4.147516,"eighty":-2.411759,"marketCap":96138786.97},{"date":"2022-04-01","current":-9.128243,"twenty":-12.421685,"median":-4.149137,"eighty":-2.411759,"marketCap":104398752.15},{"date":"2022-04-08","current":-9.863694,"twenty":-12.421685,"median":-4.164704,"eighty":-2.411759,"marketCap":112204560.57},{"date":"2022-04-14","current":-9.733909,"twenty":-12.421685,"median":-4.17509,"eighty":-2.411759,"marketCap":110055464.18},{"date":"2022-04-22","current":-9.387814,"twenty":-12.421685,"median":-4.210686,"eighty":-2.411759,"marketCap":104038032.68},{"date":"2022-04-29","current":-7.267985,"twenty":-12.421685,"median":-4.220674,"eighty":-2.411759,"marketCap":78710705.41},{"date":"2022-05-06","current":-6.97528,"twenty":-12.421685,"median":-4.23077,"eighty":-2.411759,"marketCap":75707332.86},{"date":"2022-05-13","current":-6.185631,"twenty":-12.421685,"median":-4.251907,"eighty":-2.411759,"marketCap":65311187.3},{"date":"2022-05-20","current":-7.019155,"twenty":-12.421685,"median":-4.298656,"eighty":-2.411759,"marketCap":75268113.27},{"date":"2022-05-27","current":-6.844188,"twenty":-12.421685,"median":-4.306423,"eighty":-2.411759,"marketCap":74714930.25},{"date":"2022-06-03","current":-7.107956,"twenty":-12.421685,"median":-4.34538,"eighty":-2.411759,"marketCap":78266237.1},{"date":"2022-06-10","current":-6.88008,"twenty":-12.421685,"median":-4.363747,"eighty":-2.421292,"marketCap":73995154.7},{"date":"2022-06-17","current":-6.575163,"twenty":-12.421685,"median":-4.373415,"eighty":-2.421292,"marketCap":69443299.19},{"date":"2022-06-24","current":-6.001118,"twenty":-12.431695,"median":-4.407052,"eighty":-2.421292,"marketCap":63649254.93},{"date":"2022-07-01","current":-5.591951,"twenty":-12.431695,"median":-4.442308,"eighty":-2.421292,"marketCap":57924623.95},{"date":"2022-07-08","current":-5.660709,"twenty":-12.431695,"median":-4.477564,"eighty":-2.421292,"marketCap":59313253.23},{"date":"2022-07-15","current":-5.112898,"twenty":-12.431695,"median":-4.497241,"eighty":-2.430007,"marketCap":53081227.97},{"date":"2022-07-22","current":-5.021597,"twenty":-12.431695,"median":-4.542589,"eighty":-2.438452,"marketCap":53275034.76},{"date":"2022-07-29","current":-4.65639,"twenty":-12.431695,"median":-4.567511,"eighty":-2.488216,"marketCap":49576264.56},{"date":"2022-08-05","current":-2.282544,"twenty":-12.431695,"median":-4.567511,"eighty":-2.488216,"marketCap":24012261.13},{"date":"2022-08-12","current":-2.282544,"twenty":-12.431695,"median":-4.567511,"eighty":-2.438452,"marketCap":24740525.61},{"date":"2022-08-19","current":-2.451413,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":25687814.32},{"date":"2022-08-26","current":-2.451413,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":25903035.59},{"date":"2022-09-02","current":-1.274908,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":21498048.16},{"date":"2022-09-09","current":-1.396328,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":23545481.29},{"date":"2022-09-16","current":-1.311189,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":21646314.13},{"date":"2022-09-23","current":-1.250703,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":20176115.58},{"date":"2022-09-30","current":-1.11343,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":17680470.3},{"date":"2022-10-07","current":-1.067673,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16832420.37},{"date":"2022-10-14","current":-1.072904,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16471341.64},{"date":"2022-10-21","current":-1.04225,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16264118.39},{"date":"2022-10-28","current":-0.919632,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":14508685.27},{"date":"2022-11-04","current":-0.828719,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":13168797.63},{"date":"2022-11-11","current":-0.656346,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10822510.03},{"date":"2022-11-18","current":-0.662975,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10926711.47},{"date":"2022-11-25","current":-0.603308,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10030499.83},{"date":"2022-12-02","current":-0.576789,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":9642281.61},{"date":"2022-12-09","current":-0.590048,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":9896160.86},{"date":"2022-12-16","current":-0.576789,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":9511326.69},{"date":"2022-12-23","current":-0.497232,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":8215910.04},{"date":"2022-12-30","current":-0.609937,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10217919.53},{"date":"2023-01-06","current":-0.67955,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":11462784.01},{"date":"2023-01-13","current":-0.895017,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":15343031.72},{"date":"2023-01-20","current":-0.95757,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16417639.82},{"date":"2023-01-27","current":-0.995872,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":17446925.15},{"date":"2023-02-03","current":-0.919267,"twenty":-12.431695,"median":-4.567511,"eighty":-2.446229,"marketCap":15778495.13},{"date":"2023-02-10","current":-0.919267,"twenty":-12.431695,"median":-4.567511,"eighty":-2.421292,"marketCap":15675881.42},{"date":"2023-02-17","current":-0.919267,"twenty":-12.431695,"median":-4.567511,"eighty":-2.409096,"marketCap":15523375.58},{"date":"2023-02-24","current":-0.919267,"twenty":-12.431695,"median":-4.565088,"eighty":-2.388688,"marketCap":15257857.91},{"date":"2023-03-03","current":-1.366426,"twenty":-12.431695,"median":-4.511174,"eighty":-2.37626,"marketCap":23089217.63},{"date":"2023-03-10","current":-1.320878,"twenty":-12.431695,"median":-4.485554,"eighty":-2.353853,"marketCap":21893935.24},{"date":"2023-03-17","current":-1.275331,"twenty":-12.431695,"median":-4.442308,"eighty":-2.338923,"marketCap":21376774.47},{"date":"2023-03-24","current":-1.275331,"twenty":-12.431695,"median":-4.426506,"eighty":-2.314041,"marketCap":21196517.5},{"date":"2023-03-31","current":-1.275331,"twenty":-12.421685,"median":-4.38357,"eighty":-2.300227,"marketCap":21406876.55},{"date":"2023-04-06","current":-1.639711,"twenty":-12.421685,"median":-4.367771,"eighty":-2.287836,"marketCap":27356198.35},{"date":"2023-04-14","current":-1.685259,"twenty":-12.431695,"median":-4.356703,"eighty":-2.269961,"marketCap":28571206.23},{"date":"2023-04-21","current":-1.821901,"twenty":-12.431695,"median":-4.311564,"eighty":-2.264277,"marketCap":30806418.54},{"date":"2023-04-28","current":-1.708032,"twenty":-12.431695,"median":-4.298656,"eighty":-2.239395,"marketCap":28314872.85},{"date":"2023-05-05","current":-1.639711,"twenty":-12.431695,"median":-4.272093,"eighty":-2.238394,"marketCap":27365317.69},{"date":"2023-05-12","current":-1.776354,"twenty":-12.431695,"median":-4.23077,"eighty":-2.214513,"marketCap":29764828.3},{"date":"2023-05-19","current":-1.730806,"twenty":-12.431695,"median":-4.220674,"eighty":-2.18963,"marketCap":28650661.95},{"date":"2023-05-26","current":-1.594164,"twenty":-12.431695,"median":-4.216164,"eighty":-2.131372,"marketCap":25964665.24},{"date":"2023-06-02","current":-1.503069,"twenty":-12.431695,"median":-4.181029,"eighty":-2.093153,"marketCap":24712514.29},{"date":"2023-06-09","current":-1.639711,"twenty":-12.431695,"median":-4.169151,"eighty":-2.040337,"marketCap":27563790.21},{"date":"2023-06-16","current":-1.548616,"twenty":-12.431695,"median":-4.149137,"eighty":-2.030384,"marketCap":26631594.53},{"date":"2023-06-23","current":-1.594164,"twenty":-12.441704,"median":-4.149137,"eighty":-1.990573,"marketCap":26931965.99},{"date":"2023-06-30","current":-1.457521,"twenty":-12.441704,"median":-4.149137,"eighty":-1.965691,"marketCap":24198884.39},{"date":"2023-07-07","current":-1.457521,"twenty":-12.441704,"median":-4.149137,"eighty":-1.940809,"marketCap":24120493.19},{"date":"2023-07-14","current":-1.274574,"twenty":-12.441704,"median":-4.149137,"eighty":-1.915927,"marketCap":21950560.72},{"date":"2023-07-21","current":-1.274574,"twenty":-12.441704,"median":-4.149137,"eighty":-1.891044,"marketCap":21643809.78},{"date":"2023-07-28","current":-1.274574,"twenty":-12.441704,"median":-4.147516,"eighty":-1.876887,"marketCap":21496523.38},{"date":"2023-08-04","current":-1.368987,"twenty":-12.441704,"median":-4.145895,"eighty":-1.866162,"marketCap":22462299.42},{"date":"2023-08-11","current":-1.321781,"twenty":-12.441704,"median":-4.145895,"eighty":-1.84128,"marketCap":21697692.96},{"date":"2023-08-18","current":-1.463493,"twenty":-12.441704,"median":-4.145895,"eighty":-1.818599,"marketCap":23503016.62},{"date":"2023-08-25","current":-1.369074,"twenty":-12.441704,"median":-4.145895,"eighty":-1.755592,"marketCap":22027676.44},{"date":"2023-09-01","current":-1.847817,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":24484233.73},{"date":"2023-09-08","current":-2.021049,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":26353067.86},{"date":"2023-09-15","current":-1.963305,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":25888784.15},{"date":"2023-09-22","current":-1.847817,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":24286108.15},{"date":"2023-09-29","current":-1.905561,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":25009713.33},{"date":"2023-10-06","current":-1.847817,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":24002474.77},{"date":"2023-10-13","current":-1.154885,"twenty":-12.441704,"median":-4.145895,"eighty":-1.730806,"marketCap":14966398.81},{"date":"2023-10-20","current":-1.039397,"twenty":-12.441704,"median":-4.145895,"eighty":-1.698405,"marketCap":13448468.74},{"date":"2023-10-27","current":-0.981653,"twenty":-12.461723,"median":-4.145895,"eighty":-1.690641,"marketCap":12665298.2},{"date":"2023-11-03","current":-0.635187,"twenty":-12.461723,"median":-4.145895,"eighty":-1.676652,"marketCap":8341385.4},{"date":"2023-11-10","current":-0.843066,"twenty":-12.461723,"median":-4.145895,"eighty":-1.639711,"marketCap":11079113.85},{"date":"2023-11-16","current":-0.923908,"twenty":-12.461723,"median":-4.145895,"eighty":-1.639711,"marketCap":12219963.16},{"date":"2023-11-24","current":-1.232113,"twenty":-12.461723,"median":-4.145895,"eighty":-1.639711,"marketCap":16544455},{"date":"2023-12-01","current":-0.977856,"twenty":-12.461723,"median":-4.145895,"eighty":-1.594164,"marketCap":13252109},{"date":"2023-12-08","current":-0.981556,"twenty":-12.461723,"median":-4.11076,"eighty":-1.594164,"marketCap":13243494},{"date":"2023-12-15","current":-0.970914,"twenty":-12.461723,"median":-4.11076,"eighty":-1.594164,"marketCap":13332832},{"date":"2023-12-21","current":-0.900502,"twenty":-12.461723,"median":-4.11076,"eighty":-1.592458,"marketCap":12476425},{"date":"2023-12-29","current":-0.989246,"twenty":-12.461723,"median":-4.125,"eighty":-1.548616,"marketCap":13862695},{"date":"2024-01-05","current":-0.901456,"twenty":-12.461723,"median":-4.135447,"eighty":-1.548616,"marketCap":12384007},{"date":"2024-01-12","current":-0.791699,"twenty":-12.461723,"median":-4.135447,"eighty":-1.503069,"marketCap":10782096},{"date":"2024-01-19","current":-0.769505,"twenty":-12.461723,"median":-4.145895,"eighty":-1.463493,"marketCap":10335409},{"date":"2024-01-26","current":-0.844707,"twenty":-12.461723,"median":-4.071317,"eighty":-1.4634,"marketCap":11382812},{"date":"2024-02-02","current":-0.58758,"twenty":-12.461723,"median":-4.001142,"eighty":-1.457135,"marketCap":7882101},{"date":"2024-02-09","current":-0.564955,"twenty":-12.461723,"median":-3.878135,"eighty":-1.418364,"marketCap":7494586},{"date":"2024-02-16","current":-0.614224,"twenty":-12.461723,"median":-3.831621,"eighty":-1.416212,"marketCap":8179987},{"date":"2024-02-23","current":-0.58972,"twenty":-12.461723,"median":-3.831411,"eighty":-1.374525,"marketCap":7895282},{"date":"2024-03-01","current":-0.505287,"twenty":-12.461723,"median":-3.831411,"eighty":-1.368987,"marketCap":6724829},{"date":"2024-03-08","current":-0.427661,"twenty":-12.461723,"median":-3.831411,"eighty":-1.365973,"marketCap":5796903},{"date":"2024-03-15","current":-0.43677,"twenty":-12.461723,"median":-3.831411,"eighty":-1.321815,"marketCap":5889168},{"date":"2024-03-22","current":-0.498231,"twenty":-12.461723,"median":-3.831411,"eighty":-1.320878,"marketCap":6701104},{"date":"2024-03-28","current":-0.807178,"twenty":-12.461723,"median":-3.831411,"eighty":-1.311398,"marketCap":8269616},{"date":"2024-04-05","current":-0.845438,"twenty":-12.461723,"median":-3.831411,"eighty":-1.276404,"marketCap":8783666},{"date":"2024-04-12","current":-0.928185,"twenty":-12.461723,"median":-3.831411,"eighty":-1.275331,"marketCap":9490155},{"date":"2024-04-19","current":-0.902544,"twenty":-12.461723,"median":-3.831411,"eighty":-1.275331,"marketCap":9126366},{"date":"2024-04-26","current":-0.954833,"twenty":-12.461723,"median":-3.831411,"eighty":-1.274908,"marketCap":9752453},{"date":"2024-05-03","current":-0.725,"twenty":-12.461723,"median":-3.831411,"eighty":-1.274574,"marketCap":7447136},{"date":"2024-05-10","current":-0.73121,"twenty":-12.461723,"median":-3.831411,"eighty":-1.239549,"marketCap":7586852},{"date":"2024-05-17","current":-0.739918,"twenty":-12.461723,"median":-3.831411,"eighty":-1.227368,"marketCap":7758202},{"date":"2024-05-24","current":-0.684308,"twenty":-12.461723,"median":-3.831411,"eighty":-1.180978,"marketCap":7117616},{"date":"2024-05-31","current":-0.630805,"twenty":-12.461723,"median":-3.831411,"eighty":-1.142482,"marketCap":6582477},{"date":"2024-06-07","current":-0.641014,"twenty":-12.461723,"median":-3.831411,"eighty":-1.128683,"marketCap":6705058},{"date":"2024-06-14","current":-0.691832,"twenty":-12.461723,"median":-3.831411,"eighty":-1.100941,"marketCap":7213068},{"date":"2024-06-21","current":-0.768927,"twenty":-12.461723,"median":-3.831411,"eighty":-1.085592,"marketCap":8037674},{"date":"2024-06-28","current":-0.633491,"twenty":-12.461723,"median":-3.831831,"eighty":-1.072904,"marketCap":6608754},{"date":"2024-07-05","current":-0.592608,"twenty":-12.461723,"median":-3.831831,"eighty":-1.067673,"marketCap":6260455},{"date":"2024-07-12","current":-3.472596,"twenty":-12.461723,"median":-3.831831,"eighty":-1.052207,"marketCap":36913763},{"date":"2024-07-15","current":-2.505613,"twenty":-12.461723,"median":-3.831831,"eighty":-1.052207,"marketCap":26667217},{"date":"2024-08-02","current":-1.015603,"twenty":-12.468565,"median":-3.934526,"eighty":-1.039174,"marketCap":10396820},{"date":"2024-08-09","current":-1.131852,"twenty":-12.468565,"median":-3.934526,"eighty":-1.027693,"marketCap":11679005},{"date":"2024-08-16","current":-1.102072,"twenty":-12.468565,"median":-3.934526,"eighty":-1.026273,"marketCap":11470451},{"date":"2024-08-23","current":-0.995104,"twenty":-12.468565,"median":-3.934526,"eighty":-1.022854,"marketCap":10484290},{"date":"2024-08-30","current":-1.093789,"twenty":-12.468565,"median":-3.934526,"eighty":-1.015595,"marketCap":11664108},{"date":"2024-09-06","current":-1.157689,"twenty":-12.468565,"median":-3.934526,"eighty":-1.015595,"marketCap":12215286},{"date":"2024-09-13","current":-0.981872,"twenty":-12.468565,"median":-3.934526,"eighty":-1.014085,"marketCap":10323406},{"date":"2024-09-20","current":-0.920424,"twenty":-12.468565,"median":-3.934526,"eighty":-1.004724,"marketCap":9840753},{"date":"2024-09-27","current":-1.00335,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":10856708},{"date":"2024-10-04","current":-1.188007,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":12769443},{"date":"2024-10-11","current":-1.136699,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":12006732},{"date":"2024-10-18","current":-1.490969,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":15698132},{"date":"2024-10-25","current":-1.510511,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":15730905},{"date":"2024-10-31","current":-1.642834,"twenty":-12.47672,"median":-3.934526,"eighty":-0.995872,"marketCap":16922639},{"date":"2024-11-08","current":-1.667321,"twenty":-12.484874,"median":-3.959251,"eighty":-0.995872,"marketCap":17458920},{"date":"2024-11-15","current":-1.541747,"twenty":-12.484874,"median":-3.959251,"eighty":-0.995872,"marketCap":15701111},{"date":"2024-11-22","current":-0.944872,"twenty":-12.484874,"median":-3.959251,"eighty":-0.989314,"marketCap":16475739},{"date":"2024-11-29","current":-1.293751,"twenty":-12.484874,"median":-3.888446,"eighty":-0.989314,"marketCap":22515169},{"date":"2024-12-06","current":-1.131503,"twenty":-12.484874,"median":-3.831831,"eighty":-0.989314,"marketCap":19510243},{"date":"2024-12-13","current":-0.935101,"twenty":-12.484874,"median":-3.831411,"eighty":-0.981228,"marketCap":15982721},{"date":"2024-12-20","current":-0.78721,"twenty":-12.484874,"median":-3.737961,"eighty":-0.968918,"marketCap":13195543},{"date":"2024-12-27","current":-0.789276,"twenty":-12.484874,"median":-3.718062,"eighty":-0.95757,"marketCap":13151994},{"date":"2025-01-03","current":-0.457559,"twenty":-12.484874,"median":-3.687691,"eighty":-0.95757,"marketCap":7599413},{"date":"2025-01-10","current":-0.443989,"twenty":-12.493029,"median":-3.564494,"eighty":-0.95757,"marketCap":7359890},{"date":"2025-01-17","current":-0.381761,"twenty":-12.493029,"median":-3.519938,"eighty":-0.954818,"marketCap":6358248},{"date":"2025-01-24","current":-0.380765,"twenty":-12.493029,"median":-3.430825,"eighty":-0.950286,"marketCap":6401798},{"date":"2025-01-31","current":-0.636156,"twenty":-12.493029,"median":-3.183389,"eighty":-0.944606,"marketCap":10619658},{"date":"2025-02-07","current":-0.49819,"twenty":-12.493029,"median":-3.147621,"eighty":-0.936056,"marketCap":8383941},{"date":"2025-02-14","current":-0.311295,"twenty":-12.493029,"median":-3.040316,"eighty":-0.924931,"marketCap":5252259},{"date":"2025-02-21","current":-0.287004,"twenty":-12.493029,"median":-2.754168,"eighty":-0.923908,"marketCap":4912989},{"date":"2025-02-28","current":-0.280424,"twenty":-12.493029,"median":-2.451413,"eighty":-0.919949,"marketCap":4695006},{"date":"2025-03-07","current":-0.277205,"twenty":-12.501183,"median":-2.375858,"eighty":-0.919267,"marketCap":4723512},{"date":"2025-03-14","current":-0.318521,"twenty":-12.501183,"median":-2.282544,"eighty":-0.908486,"marketCap":5365722},{"date":"2025-03-21","current":-0.323944,"twenty":-12.501183,"median":-2.168417,"eighty":-0.900754,"marketCap":5460181},{"date":"2025-03-28","current":-0.314271,"twenty":-12.501183,"median":-1.994749,"eighty":-0.898014,"marketCap":5309829},{"date":"2025-04-04","current":-0.257786,"twenty":-12.501183,"median":-1.963305,"eighty":-0.895017,"marketCap":4388713},{"date":"2025-04-11","current":-0.245199,"twenty":-12.493029,"median":-1.905561,"eighty":-0.870721,"marketCap":4080743},{"date":"2025-04-17","current":-1.157979,"twenty":-12.493029,"median":-1.881668,"eighty":-0.854775,"marketCap":19783306},{"date":"2025-04-25","current":-0.223022,"twenty":-12.501183,"median":-1.847817,"eighty":-0.838925,"marketCap":3820167},{"date":"2025-05-02","current":-0.256851,"twenty":-12.501183,"median":-1.847817,"eighty":-0.827669,"marketCap":4393181},{"date":"2025-05-09","current":-0.21211,"twenty":-12.501183,"median":-1.821901,"eighty":-0.807426,"marketCap":3644217},{"date":"2025-05-16","current":-0.221956,"twenty":-12.501183,"median":-1.776354,"eighty":-0.800489,"marketCap":3800717},{"date":"2025-05-23","current":-0.227118,"twenty":-12.501183,"median":-1.730806,"eighty":-0.795668,"marketCap":3901324},{"date":"2025-05-30","current":-0.244855,"twenty":-12.501183,"median":-1.730806,"eighty":-0.789761,"marketCap":4225503},{"date":"2025-06-06","current":-0.342012,"twenty":-12.501183,"median":-1.685259,"eighty":-0.787597,"marketCap":5974951},{"date":"2025-06-13","current":-0.590795,"twenty":-12.501183,"median":-1.655788,"eighty":-0.777296,"marketCap":10943829},{"date":"2025-06-20","current":-0.543264,"twenty":-12.509338,"median":-1.639711,"eighty":-0.768927,"marketCap":9960114},{"date":"2025-06-27","current":-0.3926,"twenty":-12.509338,"median":-1.639711,"eighty":-0.76103,"marketCap":7299612},{"date":"2025-07-03","current":-0.404205,"twenty":-12.509338,"median":-1.639711,"eighty":-0.759204,"marketCap":7545541},{"date":"2025-07-11","current":-0.621115,"twenty":-12.509338,"median":-1.594381,"eighty":-0.73121,"marketCap":11581008},{"date":"2025-07-18","current":-0.623357,"twenty":-12.509338,"median":-1.594164,"eighty":-0.715356,"marketCap":11480401},{"date":"2025-07-25","current":-0.593254,"twenty":-12.509338,"median":-1.594164,"eighty":-0.707088,"marketCap":11133865},{"date":"2025-08-01","current":-0.512794,"twenty":-12.509338,"median":-1.594164,"eighty":-0.696124,"marketCap":9367650},{"date":"2025-08-08","current":-0.498877,"twenty":-12.509338,"median":-1.548616,"eighty":-0.691832,"marketCap":9211149},{"date":"2025-08-15","current":-0.501215,"twenty":-12.509338,"median":-1.548616,"eighty":-0.684308,"marketCap":9244685},{"date":"2025-08-22","current":-0.447282,"twenty":-12.509338,"median":-1.503069,"eighty":-0.662975,"marketCap":8160363},{"date":"2025-08-29","current":-0.466145,"twenty":-12.509338,"median":-1.463493,"eighty":-0.656346,"marketCap":8641042},{"date":"2025-09-05","current":-0.489255,"twenty":-12.509338,"median":-1.4634,"eighty":-0.652939,"marketCap":9043471},{"date":"2025-09-12","current":-0.48198,"twenty":-12.509338,"median":-1.457521,"eighty":-0.647962,"marketCap":9110542},{"date":"2025-09-19","current":-0.459727,"twenty":-12.509338,"median":-1.431745,"eighty":-0.636156,"marketCap":8641042},{"date":"2025-09-26","current":-0.440581,"twenty":-12.509338,"median":-1.416284,"eighty":-0.630805,"marketCap":8193899},{"date":"2025-10-03","current":-0.377089,"twenty":-12.509338,"median":-1.411973,"eighty":-0.618501,"marketCap":7053683},{"date":"2025-10-10","current":-0.431199,"twenty":-12.509338,"median":-1.369074,"eighty":-0.611352,"marketCap":8026220},{"date":"2025-10-17","current":-0.423198,"twenty":-12.509338,"median":-1.366426,"eighty":-0.603308,"marketCap":7813827},{"date":"2025-10-24","current":-0.407347,"twenty":-12.509338,"median":-1.365973,"eighty":-0.59245,"marketCap":7534362},{"date":"2025-10-31","current":-0.461136,"twenty":-12.509338,"median":-1.321781,"eighty":-0.589121,"marketCap":8585149},{"date":"2025-11-07","current":-0.456526,"twenty":-12.509338,"median":-1.320878,"eighty":-0.576789,"marketCap":8383935},{"date":"2025-11-14","current":-0.60058,"twenty":-12.509338,"median":-1.311189,"eighty":-0.576789,"marketCap":8149184},{"date":"2025-11-21","current":-1.024803,"twenty":-12.468565,"median":-1.280696,"eighty":-0.576789,"marketCap":13722815},{"date":"2025-11-28","current":-1.4312,"twenty":-12.461723,"median":-1.275331,"eighty":-0.576789,"marketCap":19355040},{"date":"2025-12-05","current":-1.791162,"twenty":-12.411676,"median":-1.275331,"eighty":-0.576789,"marketCap":24546961},{"date":"2025-12-12","current":-1.738946,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":23996581},{"date":"2025-12-19","current":-1.335479,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":18309317},{"date":"2025-12-26","current":-1.058046,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":14676808},{"date":"2026-01-02","current":-5.435019,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":75075569},{"date":"2026-01-09","current":-5.334687,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":73876975},{"date":"2026-01-16","current":-5.499054,"twenty":-12.311582,"median":-1.275331,"eighty":-0.576789,"marketCap":76383126},{"date":"2026-01-23","current":-5.390625,"twenty":-12.311582,"median":-1.275331,"eighty":-0.576789,"marketCap":76274163},{"date":"2026-01-30","current":-4.588381,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":66467484},{"date":"2026-02-06","current":-4.246852,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":61237256},{"date":"2026-02-10","current":-4.25769,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":62326887}],"updateTime":1770846084282},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KZIA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588560210","title":"BRIEF-Kazia Therapeutics Announces Pricing Of $50.0 Million Private Placement Of Equity Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2588560210","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588560210?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:05","pubTimestamp":1764684350,"startTime":"0","endTime":"0","summary":"BRIEF-Kazia Therapeutics Announces Pricing Of $50.0 Million Private Placement Of Equity SecuritiesDec 2 (Reuters) - Kazia Therapeutics Ltd KZIA.O:KAZIA THERAPEUTICS ANNOUNCES PRICING OF $50.0 MILLION ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA9BPC49:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2584920227","title":"BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2584920227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584920227?lang=en_us&edition=fundamental","pubTime":"2025-11-20 02:59","pubTimestamp":1763578756,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, AlphabetEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL6N3WV0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","SCCO","NNE","GLBE","NVDA","OWL","SION","VTVT","GLAD","LZB","DOW","OLMA","CDE","KZIA","PPL","NUVL","COP","CEVA","H","DLB","LOW","STX","ON","NEM","VVV","COIN","MSTR","CSIQ","RDW","XOM","ZION","RIOT","CVX","GEV","DY","ACHR","OKLO","NNOX","FCX","TGT","AGIO","ALZN","GOOGL","SHBI","SNDK","WDC","RAPP","OXY","PLUG","PRAX"],"gpt_icon":0},{"id":"2584692680","title":"BUZZ-Microcap Kazia shares soar 40% after positive drug update on single-patient treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584692680","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584692680?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:38","pubTimestamp":1763570337,"startTime":"0","endTime":"0","summary":"BUZZ-Microcap Kazia shares soar 40% after positive drug update on single-patient treatment** Shares in microcap Kazia Therapeutics KZIA.O jump 34% to $7.79 on Wednesday after it reported positive early stage results in one patient with stage IV triple-negative breast cancer treated under an FDA-authorized single-patient protocol combining Kazia's drug, paxalisib,  with pembrolizumab , from Merck & Co MRK.N** Kazia said that, along with chemotherapy, the treatment of the patient with a highly aggressive metastatic cancer subtype achieved \"an initial immune-complete response \" as per iRECIST criteria** The Sydney-based co's latest results follow its October 2 report of an 86% reduction in tumor burden after three weeks of treatment in the same patient** KZIA says the patient remains on therapy, under active clinical monitoring and that a follow-up scan will be conducted to confirm the initial scan** KZIA has just 1.67 million shares outstanding and a market value of $9.6 million** Sessio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL6N3WV0YE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","LU1934455863.HKD","LU0289739699.SGD","LU0006306889.USD","LU0234572021.USD","BK4533","LU1093756325.SGD","LU0265550359.USD","LU1037948897.HKD","LU0265550946.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU1989772840.SGD","BK4139","LU2361045086.USD","LU1066051498.USD","LU1023059063.AUD","LU1093756168.USD","LU0965508806.USD","LU2112291526.USD","LU0058720904.USD","LU1974910355.USD","LU1929549753.HKD","SG9999002224.SGD","LU1066051811.HKD","LU1989771016.USD","LU0320765646.SGD","LU0965509010.AUD","LU1057294990.SGD","SGXZ57979304.SGD","LU0208291251.USD","LU1066053197.SGD","SG9999014542.SGD","LU2468319806.SGD","LU1699723380.USD","IE000M9KFDE8.USD","LU1934455277.USD","SG9999001440.SGD","KZIA","BK4534","LU2361044865.SGD","SG9999001176.USD","SG9999015341.SGD","LU1989772923.USD","LU0861579265.USD","IE00BLSP4239.USD","LU2361044949.HKD"],"gpt_icon":1},{"id":"2584911038","title":"What Sparked Kazia Therapeutics' Over 51% After-Hours Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584911038","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584911038?lang=en_us&edition=fundamental","pubTime":"2025-11-19 16:52","pubTimestamp":1763542320,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics jumped 51.74% in after-hours trading Tuesday after reporting a rare immune-complete response in a patient.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/19/SP-500-Nears-7-000.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/19/SP-500-Nears-7-000.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/11/48943376/what-sparked-kazia-therapeutics-over-51-after-hours-surge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48943376/what-sparked-kazia-therapeutics-over-51-after-hours-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","BK4139","KZIA","LENZ","BK4539"],"gpt_icon":0},{"id":"2584965200","title":"Kazia Therapeutics Reports Initial iCR in Metastatic TNBC and Advances Pipeline Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584965200","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584965200?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:15","pubTimestamp":1763500526,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited announced a business update, reporting an initial immune-complete response  in a patient with stage IV triple-negative breast cancer  under an FDA-authorized single-patient expanded access protocol. The patient was treated with a combination of paxalisib, pembrolizumab , and standard chemotherapy, resulting in a radiologic response per iRECIST criteria. The company noted that this outcome supports the mechanistic hypothesis for paxalisib in enhancing anti-tumor immunity when combined with checkpoint blockade. Kazia also announced the acceptance of two scientific presentations related to its paxalisib and NDL2 programs at the 2025 Brisbane Cancer Conference, scheduled for November 27-28, 2025. The NDL2 PD-L1 degrader program, developed in collaboration with QIMR Berghofer, is advancing toward IND-enabling studies anticipated in early 2026. The program targets resistant forms of the PD-L1 protein and aims to address resistance mechanisms to current checkpoint i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL15p3hT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2581783971","title":"Kazia Therapeutics reports A$42,000 revenue for fiscal year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783971","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581783971?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:02","pubTimestamp":1762549376,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited reported revenue of A$42,000 for the fiscal year ended June 30, 2025, a decrease from A$2.3 million in 2024. Finance income rose to A$72,000 from A$12,000 in the previous year. The company recorded a research and development rebate of A$209,000 and other sundry income of A$1.6 million in 2025. Total spending on company-sponsored research and development activities was A$7.3 million in 2025, compared to A$17.4 million in 2024 and A$15.6 million in 2023. The company noted that future research and development expenditures may vary depending on the number and stage of drug candidates and the associated trial costs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL99VLhs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2580415159","title":"Kazia Therapeutics Delays Annual Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580415159","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580415159?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:01","pubTimestamp":1761940904,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited has announced a delay in filing its Annual Report on Form 20-F for the fiscal year ended June 30, 2025. The company cited the need for additional time to finalize consolidated financial statements and complete audit procedures, and expects to file the report within fifteen days of the original deadline.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL32pHwS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2578564891","title":"BRIEF-Kazia Therapeutics To Request FDA Type C Meeting To Discuss Overall Survival Data In GBM And Potential NDA Filing In Alignment With FDA Initiative Project Frontrunner","url":"https://stock-news.laohu8.com/highlight/detail?id=2578564891","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578564891?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:23","pubTimestamp":1761564231,"startTime":"0","endTime":"0","summary":"BRIEF-Kazia Therapeutics To Request FDA Type C Meeting To Discuss Overall Survival Data In GBM And Potential NDA Filing In Alignment With FDA Initiative Project FrontrunnerOct 27 (Reuters) - Kazia The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA3SPB3W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2578648332","title":"Kazia Therapeutics Ltd - Seeks FDA Feedback on Regulatory Pathway Under Project Frontrunner for Paxalisib","url":"https://stock-news.laohu8.com/highlight/detail?id=2578648332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578648332?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:15","pubTimestamp":1761563734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA3SPB3W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2578610221","title":"Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential Nda Filing in Alignment With FDA Initiative Project Frontrunner","url":"https://stock-news.laohu8.com/highlight/detail?id=2578610221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578610221?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:15","pubTimestamp":1761563734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA3SPB3W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2573499646","title":"Kazia Therapeutics Enters Exclusive Collaboration with QIMR Berghofer to Develop First-in-Class PD-L1 Protein Degrader for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2573499646","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573499646?lang=en_us&edition=fundamental","pubTime":"2025-10-08 05:18","pubTimestamp":1759871895,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Enters Exclusive Collaboration with QIMR Berghofer to Develop First-in-Class PD-L1 Protein Degrader for Cancer Treatment. Kazia Therapeutics Limited has announced an exclusive collaboration and in-licensing agreement with QIMR Berghofer for the development of a first-in-class PD-L1 protein degrader program. The partnership centers on NDL2, an advanced PD-L1 protein degrader and a novel candidate in the field of cancer immunotherapy. This agreement marks a significant step forward in Kazia Therapeutics' efforts to expand its oncology pipeline and develop innovative cancer treatments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDLksNrR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2573501529","title":"BRIEF-Kazia Therapeutics Announces Collaboration And In-Licensing Agreement For First-In-Class PD-L1 Protein Degrader Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2573501529","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573501529?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:50","pubTimestamp":1759841420,"startTime":"0","endTime":"0","summary":"BRIEF-Kazia Therapeutics Announces Collaboration And In-Licensing Agreement For First-In-Class PD-L1 Protein Degrader ProgramOct 7 (Reuters) - Kazia Therapeutics Ltd KZIA.O:KAZIA THERAPEUTICS ANNOUNCE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nTUA8DVWXF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2573595037","title":"Kazia Therapeutics signs collaboration and in-licensing agreement for PD-L1","url":"https://stock-news.laohu8.com/highlight/detail?id=2573595037","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573595037?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:35","pubTimestamp":1759840515,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics (KZIA) announced an exclusive collaboration and in-licensing agreement with QIMR Berghofer for a first-in-class PD-L1 degrader p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-signs-collaboration-and-in-licensing-agreement-for-pd-l1-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-signs-collaboration-and-in-licensing-agreement-for-pd-l1-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZIA","LU1169589451.USD","LENZ","BK4023","LU1169590202.USD","PD","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2573957799","title":"Kazia Therapeutics Announces Collaboration and in-Licensing Agreement for First-in-Class Pd-L1 Protein Degrader Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2573957799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573957799?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:31","pubTimestamp":1759840268,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nTUA8DVWXF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2573957795","title":"Kazia Therapeutics Ltd - to Make $1.39 Mln Payment Under Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2573957795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573957795?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:31","pubTimestamp":1759840268,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nTUA8DVWXF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2572512997","title":"Kazia Therapeutics Ltd: Announces 86% Tumor Reduction in Tnbc Patient Treated With Paxalisib-Immunotherapy Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2572512997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572512997?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:31","pubTimestamp":1759408286,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VI1DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2572129415","title":"Kazia Therapeutics Ltd - Imaging Shows 86% Tumor Reduction After Three Weeks of Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2572129415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572129415?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:31","pubTimestamp":1759408286,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VI1DZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2572129505","title":"Kazia Therapeutics Announces Promising Results in Phase 1b Trial for Paxalisib Combination Therapy in Advanced Breast Cancer, Reports 86% Tumor Reduction in Metastatic TNBC Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2572129505","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572129505?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:30","pubTimestamp":1759408247,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Announces Promising Results in Phase 1b Trial for Paxalisib Combination Therapy in Advanced Breast Cancer, Reports 86% Tumor Reduction in Metastatic TNBC Patient. Kazia Therapeutics Limited  has announced results from an expanded-access case involving a patient with metastatic triple-negative breast cancer  treated with a combination of the company's investigational pan-PI3K/mTOR inhibitor, paxalisib, alongside immunotherapy and chemotherapy. Imaging conducted after three weeks of treatment showed an 86% reduction in overall tumor burden. The findings were reported by the company and are consistent with the approach being evaluated in Kazia's ongoing Phase 1b trial, which is assessing paxalisib in combination with pembrolizumab  and chemotherapy in advanced breast cancer. The company has not indicated plans for a future presentation of these results.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL1LQL4Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2572511589","title":"Kazia Therapeutics Ltd : Maxim Group Raises Target Price to $20 From $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2572511589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572511589?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:26","pubTimestamp":1759404377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ01O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2572344875","title":"Kazia Therapeutics Joins Australian Consortium to Develop AI-Driven, Personalized Therapy Strategies for Childhood Brain Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2572344875","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572344875?lang=en_us&edition=fundamental","pubTime":"2025-10-01 21:21","pubTimestamp":1759324911,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Joins Australian Consortium to Develop AI-Driven, Personalized Therapy Strategies for Childhood Brain Cancers. Kazia Therapeutics Limited has announced its participation in a new Australian Medical Research Future Fund  project aimed at improving treatment strategies for diffuse midline glioma , including diffuse intrinsic pontine glioma . The three-year initiative, led by Professor Matt Dun of the University of Newcastle, will establish DMG-ADAPTS, an advanced AI-enabled clinical decision-making platform designed to optimize sequencing and timing of targeted therapies. Kazia will support the project by providing its investigational brain cancer drug paxalisib. The consortium will integrate multiomics data and non-invasive biomarkers to guide individualized therapy and anticipate resistance, with the goal of improving outcomes for children facing these aggressive brain tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL7KYCvR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}